Vanguard Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $428M | Buy |
|
|||||
|
2022
Q2 | $192M | Sell |
|
|||||
|
2022
Q1 | $209M | Buy |
|
|||||
|
2021
Q4 | $175M | Buy |
|
|||||
|
2021
Q3 | $148M | Sell |
|
|||||
|
2021
Q2 | $205M | Buy |
|
|||||
|
2021
Q1 | $227M | Buy |
|
|||||
|
2020
Q4 | $236M | Buy |
|
|||||
|
2020
Q3 | $294M | Sell |
|
|||||
|
2020
Q2 | $348M | Sell |
|
|||||
|
2020
Q1 | $282M | Buy |
|
|||||
|
2019
Q4 | $435M | Sell |
|
|||||
|
2019
Q3 | $272M | Buy |
|
|||||
|
2019
Q2 | $282M | Buy |
|
|||||
|
2019
Q1 | $258M | Buy |
|
|||||
|
2018
Q4 | $189M | Buy |
|
|||||
|
2018
Q3 | $160M | Buy |
|
|||||
|
2018
Q2 | $185M | Buy |
|
|||||
|
2018
Q1 | $187M | Buy |
|
|||||
|
2017
Q4 | $129M | Buy |
|
|||||
|
2017
Q3 | $99.7M | Buy |
|
|||||
|
2017
Q2 | $80.2M | Buy |
|
|||||
|
2017
Q1 | $93.5M | Buy |
|
|||||
|
2016
Q4 | $26.1M | Buy |
|
|||||
|
2016
Q3 | $34M | Buy |
|
|||||
|
2016
Q2 | $21.2M | Buy |
|
|||||
|
2016
Q1 | $13.2M | Buy |
|
|||||
|
2015
Q4 | $16.3M | Buy |
|
|||||
|
2015
Q3 | $2.05M | Buy |
|